Catherine Wainwright is the Senior Director of Product Development & Regulatory Affairs. She joined Cycle in 2014 and since this time has supported the development of NITYR® (nitisinone) tablets, Cycle’s generics portfolio and the launch of TASCENSO ODT® (fingolimod). Dr Wainwright is currently responsible for the development of Cycle’s rapidly expanding pipeline, as well as the continuous improvement of Cycle’s approved products. She also leads the maintenance of Cycle’s regulatory dossiers, product labelling and pharmacovigilance.

Prior to joining Cycle, Dr Wainwright worked in API process development and small scale manufacturing. She holds a BSc in Medicinal Chemistry from The Queen’s University of Belfast and a PhD in Chemistry from Newcastle University. She has also spent time as a post-doctoral research assistant in academia in the US.

Sonya Gade is the Director of Project Management, responsible for the Cycle Pharmaceuticals PMO.

Ms. Gade joined Cycle Pharmaceuticals in 2016 as a Project Manager, supporting the approval and the launch of Nityr (nitisnone) tablets in US and Nitisinone Tablets in Canada. She began supporting the commercial supply chain in 2018, becoming the Director of Supply Chain in April 2020, successfully launching Sajazir in the US in 2021. In 2022, Ms. Gade returned to Project Management with a focus on delivery of the Cycle Pharma pipeline.

Ms. Gade has worked within the Pharmaceutical industry for 17 years. With extensive experience within Drug Metabolism and Pharmacokinetics and Clinical Project Management with GlaxoSmithKline and LGC.

Nicki Giles is Head of Finance overseeing Cycle’s finance and accounts.

Ms Giles has more than 30 years’ accountancy experience in the banking, service and technology sectors. Ms Giles has previously worked in a variety of companies that range in size from large plcs to smaller start-ups including Plasmon Plc and Light Blue Optics.

Romina Briffa is an experienced quality assurance professional with expertise and training in pharmacy, higher education, and the pharmaceutical industry. A pharmacist by training, Dr. Briffa obtained her Master of Science specialized in industrial pharmacy and is experienced in GDP and GMP quality management systems. In her previous managerial roles, she worked with big pharma as well as generic and orphan drugs companies. She obtained her PhD in Molecular and Clinical Medicine from the University of Edinburgh and consolidated her interest in theranostics with post-doctoral training at the University of St Andrews and the University of Malta. Romina has a special interest in colorectal cancer molecular pathology, molecular and cellular biology, and translational research.

Chris Shaw is Cycle’s Head of HR with responsibility for leading the future of work strategy across the business. With over 15 years of experience in HR ranging from Fortune 500 companies to AIM listed SMEs, Mr Shaw has worked across multiple industries and brings considerable experience in HR strategic planning and execution, change management, and talent and leadership development.

Mr Shaw joined Cycle in May 2021 and is driven by the desire to deliver commercial success within industry-leading work environments that promote innovation, engagement and a continuous culture of growth and development.

Naomi joined the Cycle team in December 2021 as US Brand Manager. Naomi has worked in a variety of B2B manufacturing industries from AV, Flooring, Lighting and Plastic drainage!

After 8 years of starting her career as a receptionist/administrator Naomi decided to focus on a future in marketing, she has now been working in the marketing industry for 15 years. Starting off as a marketing assistant for an AV company working in the education sector she soon moved into a marketing executive role for Tarkett, an international flooring company, this was the start of her international marketing career.

As she started to climb the career ladder she secured a role as marketing communications manager for Helvar, a Finnish lighting company. This role saw her not just working from the UK but travelling around Europe being a frequent visitor to Head Office based in Helsinki. Due changes within the business her role was made redundant and she became International Marketing Manager at Polypipe.

In 2016 Naomi gained her Certificate in Marketing (CIM/CAM) enabling her to strengthen her marketing knowledge and experience, bringing this to the marketing team at Cycle.

Prior to Cycle, Matt has worked for various companies in varied industries including Pharma, Life Sciences, Manufacturing, and Financial Services all in accountancy roles predominantly in FP&A and business partnering capacity, Matt Graduated from Durham university with a BA in Business Finance.

James is Director of Supply Chain at Cycle.

James joined the business in 2023. He has over 15 years’ supply chain experience and has led supply chain functions at companies including Abcam, Controllis, Oval Medical Technologies and Cambridge Pharma. James completed his undergraduate studies at Robinson College, Cambridge and holds an MA from the University of Cambridge.

John Reid is Cycle’s Vice President of Patient Support. He is responsible for Cycle Vita, Cycle’s Patient Support Platform. During his time at Cycle Pharma, he has built Cycle Vita from the ground up leveraging nearly 20 years of Patient Services experience and paying close attention to every detail from the construction of the CRM to the hiring of the staff and definition of all the processes that drive Cycle Vita to provide the highest level of quality and support possible- because Every Single Patient Matters.

Prior to joining Cycle, John held critical roles across two industries with responsibility for Specialty Pharmacy Contracting, Vendor Management, Finance, Sales, and Customer Service. He is proud to use his MBA from Purdue University as a strong foundation of knowledge to bring better products and services to the rare and genetic disease space.

Zac Bohlen is Vice President, Head of Sales, US, overseeing and leading sales for all of Cycle’s branded products in the US. Mr Bohlen joined Cycle in January 2020 as Head of Operations. Mr Bohlen is an executive commercial leader with over 22 years of success in biotech, pharmaceuticals, specialty pharmacy and 503B outsourcing. He has progressed through roles of increasing responsibility in sales and marketing leadership, market access, business development and general management. Mr Bohlen has deep experience creating winning teams through positive coaching, maintaining accountability and leveraging his entrepreneurial mindset.

Prior to joining Cycle, Mr Bohlen worked in commercial roles for multiple life science companies that include Teva Pharmaceuticals, GlaxoSmithKline, Sanofi Aventis, AllCare Plus Pharmacy and RXQ Compounding.

Victoria Dickinson is Cycle’s US Brand and Product Launch Manager, responsible for product launch planning and execution in the US market, encompassing commercial readiness and supply. Ms. Dickinson also leads the development and implementation of US brand strategy.

Ms. Dickinson has 10 years’ experience in commercial marketing and communications, strategic and tactical. Prior to Cycle, she held roles in science, healthcare and technology specialist marketing agencies as well as public sector communications.

Ms. Dickinson holds an BSc (Hons) in Zoology from the University of Manchester.

Noah Sachs is US Legal Counsel based in Boston. Noah is an attorney with a specialty as in-house counsel for biotech, pharmaceutical, and technology companies. Previous clients have included Eisai Inc., Editas Medicine Inc., Takeda Pharmaceuticals, the Massachusetts Executive Office of Health and Human Services, Partners Healthcare, Philips Healthcare, and Lahey Hospital & Medical Center.

Mr Sachs is also a registered Patent Attorney and has a degree in molecular biology from The Evergreen State College. Prior to becoming an attorney, he worked as an associate scientist performing biotech and pharmaceutical research; his research included extensive work with laboratory robotics; he worked as a genetic engineer and can clone a gene from one organism to another.